HTT and Huntington disease: The lower binding of [3H]CHDI-180 to WT compared to HD brains in RAFTA and ARG experiments (see Fig. 4) also suggests that this small molecule has minimal binding to WT (unexpanded) HTT protein and is consistent with the use of fibrils (expanded mHTT) as the screening target for its discovery.